These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 26944570)
1. The change of plasma galectin-3 concentrations after traumatic brain injury. Shen YF; Yu WH; Dong XQ; Du Q; Yang DB; Wu GQ; Zhang ZY; Wang H; Jiang L Clin Chim Acta; 2016 May; 456():75-80. PubMed ID: 26944570 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of plasma nesfatin-1 concentrations in patients with traumatic brain injury. Wu GQ; Chou XM; Ji WJ; Yang XG; Lan LX; Sheng YJ; Shen YF; Li JR; Huang GZ; Yu WH; Dong XQ; Du Q; Yang DB; Zhang ZY; Wang H; Shen YF; Jiang L Clin Chim Acta; 2016 Jul; 458():124-8. PubMed ID: 27155585 [TBL] [Abstract][Full Text] [Related]
3. Serum thioredoxin and in-hospital major adverse events after traumatic brain injury. Dong XQ; Yu WH; Zhang ZY; Yang DB; Du Q; Wang H; Shen YF; Jiang L; Che ZH; Zhu Q Clin Chim Acta; 2017 Jun; 469():75-80. PubMed ID: 28347674 [TBL] [Abstract][Full Text] [Related]
4. Serum S100A12 as a prognostic biomarker of severe traumatic brain injury. Feng MJ; Ning WB; Wang W; Lv ZH; Liu XB; Zhu Y; Gao W; Jin HZ; Gao SS Clin Chim Acta; 2018 May; 480():84-91. PubMed ID: 29408171 [TBL] [Abstract][Full Text] [Related]
5. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury. Yang DB; Yu WH; Dong XQ; Zhang ZY; Du Q; Zhu Q; Che ZH; Wang H; Shen YF; Jiang L Clin Chim Acta; 2017 Jun; 469():99-104. PubMed ID: 28366792 [TBL] [Abstract][Full Text] [Related]
6. Serum CXC chemokine ligand-12 as a potential predictor for in-hospital major adverse events after severe traumatic brain injury. Shen LJ; Zhou J; Yang CS; Lv QW; Xu QC Clin Chim Acta; 2020 Oct; 509():244-248. PubMed ID: 32569633 [TBL] [Abstract][Full Text] [Related]
7. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study. Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776 [TBL] [Abstract][Full Text] [Related]
8. Plasma copeptin level predicts acute traumatic coagulopathy and progressive hemorrhagic injury after traumatic brain injury. Yang DB; Yu WH; Dong XQ; Du Q; Shen YF; Zhang ZY; Zhu Q; Che ZH; Liu QJ; Wang H; Jiang L; Du YF Peptides; 2014 Aug; 58():26-9. PubMed ID: 24905622 [TBL] [Abstract][Full Text] [Related]
9. Serum ST2 as a potential prognostic biomarker for traumatic brain injury. Du Q; Weng JF; Luo LF; Cen M; Yu WH; Zheng YK; Hu W; Pan JW; Dong XQ Clin Chim Acta; 2018 Dec; 487():145-152. PubMed ID: 30266513 [TBL] [Abstract][Full Text] [Related]
10. Role of galectin-3 in plasma as a predictive biomarker of outcome after acute intracerebral hemorrhage. Yan XJ; Yu GF; Jie YQ; Fan XF; Huang Q; Dai WM J Neurol Sci; 2016 Sep; 368():121-7. PubMed ID: 27538613 [TBL] [Abstract][Full Text] [Related]
11. Correlation of tenascin-C concentrations in serum with outcome of traumatic brain injury in humans. Zhao YY; Lou L; Yang KC; Wang HB; Xu Y; Lu G; He HY Clin Chim Acta; 2017 Sep; 472():46-50. PubMed ID: 28732652 [TBL] [Abstract][Full Text] [Related]
12. Higher plasma C-type lectin-like receptor 2 concentrations for prediction of higher risk of 30-day mortality in isolated severe blunt traumatic brain injury. Guo M; Zhang H; Lv QW; Huang HB; Shen LJ Clin Chim Acta; 2019 Sep; 496():1-6. PubMed ID: 31202718 [TBL] [Abstract][Full Text] [Related]
13. Plasma thrombospondin-1 and clinical outcomes in traumatic brain injury. Wang JL; Jin GL; Yuan ZG; Yu XB; Li JQ; Qiu TL; Dai RX Acta Neurol Scand; 2016 Sep; 134(3):189-96. PubMed ID: 26521864 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury. Zhang ZY; Li J; Ye Q; Dong Y; Bao GM; Shen YK; Weng JF; Luo LF; Cen M Clin Chim Acta; 2019 Oct; 497():6-12. PubMed ID: 31279693 [TBL] [Abstract][Full Text] [Related]
15. A two-center prospective cohort study of serum RIP-3 as a potential biomarker in relation to severity and prognosis after severe traumatic brain injury. Zou S; Xu J; Yang W; Chen Z; Shan H; Liu J; Tian D; Wu X; Du Q; Dong X; Jiang L Neurosurg Rev; 2024 Aug; 47(1):433. PubMed ID: 39141133 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of coagulation tests for in-hospital mortality in patients with traumatic brain injury. Yuan Q; Yu J; Wu X; Sun YR; Li ZQ; Du ZY; Wu XH; Hu J Scand J Trauma Resusc Emerg Med; 2018 Jan; 26(1):3. PubMed ID: 29304855 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of serum translocator protein in patients with traumatic brain injury. Luo LF; Weng JF; Cen M; Dong XQ; Yu WH; Du Q; Yang DB; Zheng YK; Hu W; Yu L; Luo SD Clin Chim Acta; 2019 Jan; 488():25-30. PubMed ID: 30385279 [TBL] [Abstract][Full Text] [Related]
18. The 90-day prognostic value of serum cyclophilin A in traumatic brain injury. Jin HH; Mao TM; Bai ZQ; Chen Y; Ji HL; Jin Y Clin Chim Acta; 2018 Sep; 484():258-264. PubMed ID: 29885319 [TBL] [Abstract][Full Text] [Related]
19. Role of signal peptide-Cub-Egf domain-containing protein-1 in serum as a predictive biomarker of outcome after severe traumatic brain injury. Chen QH; Lin D; Zhou J; Deng G Clin Chim Acta; 2016 May; 456():63-66. PubMed ID: 26940951 [TBL] [Abstract][Full Text] [Related]
20. Serum lipocalin-2 concentrations and mortality of severe traumatic brain injury. Shen LJ; Zhou J; Guo M; Yang CS; Xu QC; Lv QW; Yang SB; Huang HB Clin Chim Acta; 2017 Nov; 474():130-135. PubMed ID: 28943289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]